Key result
Blockade of reactive oxygen species generation and intrarenal renin-angiotensin system activation restored the inhibitory action of insulin on angiotensinogen gene expression in proximal tubular cells under high glucose conditions.
Why the study?
Does blockade of ROS generation and RAS activation restore the inhibitory action of insulin on angiotensinogen gene expression in renal proximal tubular cells under high glucose conditions?
Does blockade of ROS generation and RAS activation restore the inhibitory action of insulin on angiotensinogen gene expression in renal proximal tubular cells under high glucose conditions?
Blockade of ROS generation and intrarenal RAS activation restores the inhibitory action of insulin on angiotensinogen gene expression in renal proximal tubular cells exposed to high glucose.
ROS/RAS blockade may restore insulin effects in high-glucose renal cells; hypothesis-generating for diabetic nephropathy, needs human validation.
We reported previously that insulin inhibits the stimulatory effect of high glucose on the expression of angiotensinogen (ANG) gene in both rat immortalized renal proximal tubular cells (IRPTCs) and non-diabetic rat renal proximal tubular cells (RPTCs), but has no effect in diabetic rat RPTCs. In the present study we investigated whether hyperglycaemia-induced resistance to the insulin-induced inhibition of expression of the ANG gene is mediated via the generation of reactive oxygen species (ROS) in RPTCs. Rat IRPTCs were cultured for 2 weeks in high-glucose (25 mM) or normal-glucose (5 mM) medium plus angiotensin II (Ang II) with or without a superoxide scavenger (tiron), or inhibitors of: NADPH oxidase (diphenylene iodinium, DPI), Ang II type 1 and 2 receptors (losartan and PD123319), angiotensin-converting enzyme (perindopril), protein kinase C (GF 109203X), or glutamine:fructose-6-phosphate amino-transferase (azaserine). Cellular generation of ROS, and ANG and renin mRNA levels were assessed by lucigenin assay and specific reverse transcriptase-PCR respectively. Phosphorylation of p44/42 mitogen-activated protein kinase (p44/42 MAPK) was evaluated by western blotting. Prolonged exposure of IRPTCs to high concentrations of glucose or Ang II evoked generation of ROS and resistance to the insulin-induced inhibition of expression of the ANG gene and of p44/42 MAPK phosphorylation. Co-incubation of IRPTCs with tiron, DPI, losartan, PD123319, perindopril, GF 109203X or azaserine prevented ROS generation, restoring the inhibitory action of insulin on ANG gene expression and on p44/42 MAPK phosphorylation. In conclusion, our studies demonstrate that blockade of both ROS generation and activation of the intrarenal renin-angiotensin system improves the inhibitory action of insulin on ANG gene expression in IRPTCs in conditions of high glucose.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2004) studied Diabetic nephropathy (in vitro model). ROS blockade (tiron, DPI) and RAS blockers (losartan, PD123319, perindopril) vs. High glucose (25 mM) or Ang II without inhibitors was evaluated on Expression of angiotensinogen (ANG) gene and p44/42 MAPK phosphorylation. Blockade of reactive oxygen species generation and intrarenal renin-angiotensin system activation restored the inhibitory action of insulin on angiotensinogen gene expression in proximal tubular cells under high glucose conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: